Chris Chen is a Principal at the Gates Foundation’s $2.5 billion Strategic Investment Fund (SIF), the foundation’s venture capital, debt, and guarantee fund. Chris has worked on SIF’s investments in BioNTech (BNTX), Sanofi Pasteur, Vedanta Biosciences, Lodo Therapeutics, Sinopharm, and Ustar Biotechnologies.
Before joining the Gates Foundation, Chris worked on Bain Capital’s private equity investment team for five years. He partnered with management teams to build and grow companies across the healthcare, services, and industrials sectors.
Chris has an M.B.A. from the Stanford Graduate School of Business and a bachelor’s degree in Ethics, Politics, and Economics from Yale University.Back to all team members